| Overview |
| bsm-30256a-pe-100t |
| mouse CD49d/PE |
| FCM |
| Mouse |
| Specifications |
| Unconjugated |
| Rat |
| Monoclonal |
| 5A12 |
| IgG2b/Kappa |
| n/a |
| Affinity purified by Protein G |
| 0.01M PBS, 0.5%BSA, 0.02% Proclin300 |
| Store at 2-8°C |
| Target |
| 16401.0 |
| Q00651 |
| Alpha 4 subunit of VLA 4 receptor;ITG-α4: Antigen CD49D; CD 49d ; Integrin alpha 4; CD49d antigen; CDw49d; IA4; Integrin alpha IV; ITGA 4; ITGA4; LPAM23; MGC90518; Very Late Activation Antigen 4; Very Late Activation Protein 4 Receptor Alpha 4 Subunit; VLA 4; VLA4; integrin alpha-4; ITA4_HUMAN; Integrin α4; Integrin α 4. |
| Enables fibronectin binding activity. Acts upstream of or within several processes, including chorio-allantoic fusion; face development; and heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules. Located in cell-cell junction and external side of plasma membrane. Is expressed in several structures, including alimentary system; cardiovascular system; embryo mesenchyme; genitourinary system; and nervous system. Human ortholog(s) of this gene implicated in autism spectrum disorder and pancreatic cancer. Orthologous to human ITGA4 (integrin subunit alpha 4). [provided by Alliance of Genome Resources, Apr 2022] |
| Application Dilution |
| FCM |
10ul/10^6 cells in 100ul |
Powered by Bioz